International Cooperation News

  • Impact of Absorption on Pharmacokinetic Variability

    Yuji Kumagai, MD, PhD.
    Director, Clinical Trial Center
    Kitasato University East Hospital, Kanagawa, Japan
        Information of pharmacokinetic data in human is essential in drug development. Failure rate of investigational drugs in phase I trials is still approximately 10%, and microdose clinical trials are started in EU, US and Japan. The microdose trials principally aim at revealing absorption characteristics of a drug and we noticed several factors which may affect kinetics of drugs in microdose trials.  We also have several experiences of interesting pharmacokinetic data of phase I clinical trials in healthy and diseased subjects. Although original data cannot be presented by the obligation of contracts for some drugs, I'd like to share some information with Asian colleagues for the future benefits o f Asian people.

    附件下载

    Recommended Articles
    The
    The "Belt and Road" Forum on Big-health & International Symposium on Recombinant Collagen Successfully Held in Beijing 2023
    Sep 14,2023
    The "Belt and Road" Forum on Big-health & International Symposium on Recombinant Collagen was successfully held at the Palace Garden Hotel and Resorts in Beijing from August 21-22, 2023.
    Delegation from Egyptian Embassy in China Visit Institute of Process Engineering
    Aug 28,2020
    The delegation from the Egyptian Bureau for Cultural, Educational and Scienctific Affairs in the Egyptian Embassy in China, led by Counsellor Omayma Ghanem Zaidan visited Institute of Process Engineering, Chinese Academy of Sciences, to enhance th...

    CONTACT US

    • CONTACT US 86-10-82544817
    • CONTACT US 62551257
    • CONTACT US ghb@ipe.ac.cn
    • CONTACT US Institute of Process Engineering,Chinese Academy of Sciences,1 North 2nd Street, Zhongguancun, Haidian District, Beijing 100190, PR China